Yoshida, Toru <br/><br/>
Bepridil prevents paroxysmal atrial fibrillation by a class III antiarrhythmic drug effect.  [electronic resource] 

 -  Pacing and clinical electrophysiology : PACE  Jan 2003 
 - 314-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0147-8389 
<br/><br/><label>Standard No.: </label>10.1046/j.1460-9592.2003.00040.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Arrhythmia Agents--therapeutic use<br/>Atrial Fibrillation--diagnosis<br/>Bepridil--therapeutic use<br/>Electrocardiography<br/>Female<br/>Flecainide--therapeutic use<br/>Humans<br/>Lidocaine--analogs & derivatives<br/>Male<br/>Middle Aged